Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Smith

Showing results (111-120 of 319) with videos related to

Pageof 32
Sort By:
The Journal of Urology|October 19, 2010
Cardiovascular safety of degarelix: results from a 12-month, comparative, randomized, open label, parallel group phase III trial in patients with prostate cancerMatthew R Smith, Laurence Klotz, Bo-Eric Persson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancerMatthew R Smith, Won Chan Lee, Jane Brandman, et al.
Cancer Treatment Reviews|June 27, 2008
Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directionsRobert Coleman, Janet Brown, Evangelos Terpos, et al.
A&A Practice|March 11, 2025
Liberalized Epidural Programmed Intermittent Boluses With Patient-Controlled Epidural Analgesia Settings and Labor Epidural Failure Rates: A Single-Center Retrospective AnalysisChloe O'Connell Stanwyck, Sophia C Bechek, Matthew R Smith, et al.
AANA Journal|November 27, 2024
The Role of Processed Electroencephalogram in Adult Surgical Procedures: A Retrospective Cohort StudyKaylee Hutto, Maria van Pelt, Matthew R Smith, et al.
Cancer|February 26, 2004
Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapiesTerrence H Diamond, Celestia S Higano, Matthew R Smith, et al.
European Urology|March 5, 2013
Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancerNancy L Keating, Pang-Hsiang Liu, A James O'Malley, et al.
BJU International|January 15, 2008
Use of androgen deprivation therapy for metastatic prostate cancer in older menNancy L Keating, A James O'Malley, Mary McNaughton-Collins, et al.
The Journal of Urology|April 20, 2010
Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancerPhilip J Saylor, Donald S Kaufman, M Dror Michaelson, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2014
Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancerDesmond Padhi, Celestia S Higano, Neal D Shore, et al.
Pageof 32

Showing results (111-120 of 319) with videos related to

Sort By:
Pageof 32
The Journal of Urology|October 19, 2010
Cardiovascular safety of degarelix: results from a 12-month, comparative, randomized, open label, parallel group phase III trial in patients with prostate cancerMatthew R Smith, Laurence Klotz, Bo-Eric Persson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2005
Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancerMatthew R Smith, Won Chan Lee, Jane Brandman, et al.
Cancer Treatment Reviews|June 27, 2008
Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directionsRobert Coleman, Janet Brown, Evangelos Terpos, et al.
A&A Practice|March 11, 2025
Liberalized Epidural Programmed Intermittent Boluses With Patient-Controlled Epidural Analgesia Settings and Labor Epidural Failure Rates: A Single-Center Retrospective AnalysisChloe O'Connell Stanwyck, Sophia C Bechek, Matthew R Smith, et al.
AANA Journal|November 27, 2024
The Role of Processed Electroencephalogram in Adult Surgical Procedures: A Retrospective Cohort StudyKaylee Hutto, Maria van Pelt, Matthew R Smith, et al.
Cancer|February 26, 2004
Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapiesTerrence H Diamond, Celestia S Higano, Matthew R Smith, et al.
European Urology|March 5, 2013
Androgen-deprivation therapy and diabetes control among diabetic men with prostate cancerNancy L Keating, Pang-Hsiang Liu, A James O'Malley, et al.
BJU International|January 15, 2008
Use of androgen deprivation therapy for metastatic prostate cancer in older menNancy L Keating, A James O'Malley, Mary McNaughton-Collins, et al.
The Journal of Urology|April 20, 2010
Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancerPhilip J Saylor, Donald S Kaufman, M Dror Michaelson, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2014
Pharmacological inhibition of myostatin and changes in lean body mass and lower extremity muscle size in patients receiving androgen deprivation therapy for prostate cancerDesmond Padhi, Celestia S Higano, Neal D Shore, et al.
Pageof 32